A fluorogenic probe for granzyme B enables in-biopsy evaluation and screening of response to anticancer immunotherapies
Publication year
2022Source
Nature Communications, 13, 1, (2022), article 2366ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Pulmonary Diseases
Tumorimmunology
Journal title
Nature Communications
Volume
vol. 13
Issue
iss. 1
Subject
All institutes and research themes of the Radboud University Medical Center; Radboudumc 19: Nanomedicine RIMLS: Radboud Institute for Molecular Life Sciences; Radboudumc 2: Cancer development and immune defence RIMLS: Radboud Institute for Molecular Life Sciences; Radboudumc 9: Rare cancers RIMLS: Radboud Institute for Molecular Life SciencesThis item appears in the following Collection(s)
- Academic publications [232047]
- Electronic publications [115328]
- Faculty of Medical Sciences [89033]
- Open Access publications [82661]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.